Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system

Neurobiology of Disease

Volumn 48, Issue 1, 2012, Pages 9-19

  Noorian, Ali Reza ^a   Rha, Jennifer ^a   Annerino, Dana M ^a   Bernhard, Douglas ^a   Taylor, Georgia M ^a   Greene, James G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colon; Constipation; DMV; Gastric emptying; Gastrointestinal; Parkinson's disease; Stomach; Synuclein; Vagus

Indexed keywords

ALPHA SYNUCLEIN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL MOTILITY; GENOTYPE; IMMUNOREACTIVITY; INTESTINE INNERVATION; MALE; MYENTERIC PLEXUS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STOMACH EMPTYING; TRANSGENE; VAGUS NERVE; VAGUS NERVE DORSAL NUCLEUS;

AGING; ALPHA-SYNUCLEIN; ANIMALS; COLON; DISEASE MODELS, ANIMAL; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL MOTILITY; MICE; MICE, TRANSGENIC; PARKINSON DISEASE; VAGUS NERVE;

EID: 84863662763     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.06.005     Document Type: Article

References (78)

1. Abbott R.D., et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001, 57:456-462.
2. Adler J., Parmryd I. Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient. Cytometry A 2010, 77:733-742.
3. Anderson G., et al. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp. Neurol. 2007, 207:4-12.
4. Ashraf W., et al. Constipation in Parkinson's Disease: objective assessment and response to psyllium. Mov. Disord. 1997, 12:946-951.
5. Beach T.G., et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010, 119:689-702.
6. Berthoud H.R., et al. Topography of efferent vagal innervation of the rat gastrointestinal tract. Am. J. Physiol. 1991, 260:R200-R207.
7. Braak H., et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
8. Braak H., et al. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci. Lett. 2006, 396:67-72.
9. Cabin D.E., et al. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background. Neurobiol. Aging 2005, 26:25-35.
10. Chung C.Y., et al. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. J. Neurosci. 2009, 29:3365-3373.
11. Dapoigny M., et al. Vagal influence on colonic motor activity in conscious nonhuman primates. Am. J. Physiol. 1992, 262:G231-G236.
12. De Miguel J. Late results of bilateral selective vagotomy and pyloroplasty for duodenal ulcer: 5-9 year follow-up. Br. J. Surg. 1974, 61:264-270.
13. Djaldetti R., et al. First emergence of "delayed-on" and "dose failure" phenomena in a patient with Parkinson's disease following vagotomy. Mov. Disord. 1994, 9:582-583.
14. Djaldetti R., et al. Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology 1996, 46:1051-1054.
15. Djaldetti R., et al. Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's disease. Isr. J. Med. Sci. 1996, 32:1224-1227.
16. Edwards L.L., et al. Gastrointestinal symptoms in Parkinson's disease. Mov. Disord. 1991, 6:151-156.
17. Edwards L.L., et al. Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. Neurology 1992, 42:726-732.
18. Edwards L.L., et al. Characterization of swallowing and defecation in Parkinson's disease. Am. J. Gastroenterol. 1994, 89:15-25.
19. Fleming S.M., et al. Genetic mouse models of parkinsonism: strengths and limitations. NeuroRx 2005, 2:495-503.
20. Fujishiro H., et al. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease. Mov. Disord. 2008, 23:1085-1092.
21. Gai W.P., et al. Age-related loss of dorsal vagal neurons in Parkinson's disease. Neurology 1992, 42:2106-2111.
22. Gispert S., et al. Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol. Cell. Neurosci. 2003, 24:419-429.
23. Goetze O., et al. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test. Neurosci. Lett. 2005, 375:170-173.
24. Goetze O., et al. Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol. Motil. 2006, 18:369-375.
25. Goldstein D.S. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol. 2003, 2:669-676.
26. Goldstein D.S. Cardiac denervation in patients with Parkinson disease. Cleve. Clin. J. Med. 2007, 74(Suppl. 1):S91-S94.
27. Goldstein D.S., et al. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Clin. Auton. Res. 2007, 17:118-121.
28. Greene J.G., et al. Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease. Exp. Neurol. 2009, 218(1):154-161.
29. Hardoff R., et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov. Disord. 2001, 16:1041-1047.
30. Hely M.A., et al. Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov. Disord. 2005, 20:190-199.
31. Jost W.H., Schrank B. Defecatory disorders in de novo Parkinsonians-colonic transit and electromyogram of the external anal sphincter. Wien. Klin. Wochenschr. 1998, 110:535-537.
32. Katsuse O., et al. Developmental stages of cortical Lewy bodies and their reaction to axonal transport blockage in brains of patients with dementia with Lewy bodies. J. Neurol. Sci. 2003, 15:29-35.
33. Krygowska-Wajs A., et al. Evaluation of gastric emptying in familial and sporadic Parkinson disease. Parkinsonism Relat. Disord. 2009, 15(9):692-696.
34. Kuo Y.M., et al. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum. Mol. Genet. 2010, 19:1633-1650.
35. Kurlan R., et al. Erratic gastric emptying of levodopa may cause "random" fluctuations of parkinsonian mobility. Neurology 1988, 38:419-421.
36. Lebouvier T., et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One 2010, 5:e12728.
37. Lee M.K., et al. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 -> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8968-8973.
38. Lemaire-Vieille C., et al. Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5422-5427.
39. Mak S.K., et al. Decreased alpha-synuclein expression in the aging mouse substantia nigra. Exp. Neurol. 2009, 220:359-365.
40. Martin L.J., et al. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 2006, 26:41-50.
41. Maskri L., et al. Influence of different promoters on the expression pattern of mutated human alpha-synuclein in transgenic mice. Neurodegener. Dis. 2004, 1:255-265.
42. Muller T., et al. Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients. Clin. Neuropharmacol. 2006, 29:61-67.
43. Naftali T., et al. Electrogastrography in patients with Parkinson's disease. Can. J. Neurol. Sci. 2005, 32:82-86.
44. Natale G., et al. Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation. Neurogastroenterol. Motil. 2008, 20:741-749.
45. Orimo S., et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol. 2005, 109:583-588.
46. Orimo S., et al. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol. 2007, 17:24-30.
47. Orimo S., et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008, 131:642-650.
48. Patrick A., Epstein O. Review article: gastroparesis. Aliment. Pharmacol. Ther. 2008, 27:724-740.
49. Pfeiffer R.F. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 2003, 2:107-116.
50. Pfeiffer R.F. Gastrointestinal dysfunction in Parkinson's disease. Parkinsonism Relat. Disord. 2011, 17:10-15.
51. Pfeiffer R.F., Quigley E.M. Gastrointestinal motility problems in patients with Parkinson's disease: epidemiology, pathophysiology, and guidelines for management. CNS Drugs 1999, 11:435-448.
52. Phillips R.J., Powley T.L. Gastric volume detection after selective vagotomies in rats. Am. J. Physiol. 1998, 274:R1626-R1638.
53. Polymeropoulos M.H., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
54. Powley T.L., et al. Gastrointestinal tract innervation of the mouse: afferent regeneration and meal patterning after vagotomy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R563-R574.
55. Saha A.R., et al. Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons. J. Cell Sci. 2004, 117:1017-1024.
56. Sakakibara R., et al. Bladder and bowel dysfunction in Parkinson's disease. J. Neural Transm. 2008, 115:443-460.
57. Siddiqui M.F., et al. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat. Disord. 2002, 8:277-284.
58. Singer C., et al. Autonomic dysfunction in men with Parkinson's disease. Eur. Neurol. 1992, 32:134-140.
59. Singleton A., et al. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain 2004, 127:768-772.
60. Spillantini M.G., et al. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
61. Sturrock R.R. A comparison of age-related changes in neuron number in the dorsal motor nucleus of the vagus and the nucleus ambiguus of the mouse. J. Anat. 1990, 173:169-176.
62. Temlett J.A., Thompson P.D. Reasons for admission to hospital for Parkinson's disease. Intern. Med. J. 2006, 36:524-526.
63. Tobi M., et al. Delayed gastric emptying after laparoscopic anterior highly selective and posterior truncal vagotomy. Am. J. Gastroenterol. 1995, 90:810-811.
64. Tong W.D., et al. Effects of autonomic nerve stimulation on colorectal motility in rats. Neurogastroenterol. Motil. 2010, 22:688-693.
65. Travagli R.A., et al. Brainstem circuits regulating gastric function. Annu. Rev. Physiol. 2006, 68:279-305.
66. Tsukamoto K., et al. Peripherally administered CRF stimulates colonic motility via central CRF receptors and vagal pathways in conscious rats. Am. J. Physiol. 2006, 290:R1537-R1541.
67. Ueki A., Otsuka M. Life style risks of Parkinson's disease: association between decreased water intake and constipation. J. Neurol. 2004, 251(Suppl. 7):vII18-vII23.
68. Wakabayashi K., Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur. Neurol. 1997, 38(Suppl. 2):2-7.
69. Wakabayashi K., et al. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol. (Berl.) 1988, 76:217-221.
70. Wakabayashi K., et al. Lewy bodies in the enteric nervous system in Parkinson's disease. Arch. Histol. Cytol. 1989, 52:191-194. (Suppl.).
71. Wakabayashi K., et al. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol. (Berl.) 1990, 79:581-583.
72. Wakabayashi K., et al. Lewy bodies in the visceral autonomic nervous system in Parkinson's disease. Adv. Neurol. 1993, 60:609-612.
73. Wakabayashi K., et al. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol. 2010, 120:1-12.
74. Walter G.C., et al. Versatile, high-resolution anterograde labeling of vagal efferent projections with dextran amines. J. Neurosci. Methods 2009, 178:1-9.
75. Wang L., et al. Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein. Neuroreport 2008, 19:873-876.
76. Whited K.L., et al. A non-invasive method for measurement of gastric emptying in mice: effects of altering fat content and CCK A receptor blockade. Neurogastroenterol. Motil. 2004, 16:421-427.
77. Whited K.L., et al. Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G156-G162.
78. Woodford H., Walker R. Emergency hospital admissions in idiopathic Parkinson's disease. Mov. Disord. 2005, 20:1104-1108.